文献速递妇科

术中算法指导早期子宫内膜癌手术分期的前瞻性验证

Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2017-02-09

在学术癌症中心前瞻性纳入2012年1月至2015年6月临床局限于子宫的子宫内膜癌患者,按Mayo Clinic方案依据细胞类型、肿瘤分级、肌层浸润和肿瘤大小术中分层。194例可分析,算法识别132例(68%)高危和62例(32%)低危;高危中126例接受淋巴结清扫,14例(11%)淋巴结转移阳性。算法敏感性90%(18/20)、特异性36%(62/174),作者认为需修改以更好匹配手术与转移风险。

要点

  • 术中评估可用于确定早期子宫内膜癌手术分期范围。
  • 高危132例中126例清扫,14例(11%)淋巴结转移阳性。
  • 算法敏感性90%(18/20)、特异性36%(62/174)。

核心结论

  • 术中评估早期子宫内膜癌可用于确定手术分期范围。
  • 所研究算法特异性低,需修改以更好匹配手术方式与转移癌风险。

研究设计与样本

  • 前瞻性验证研究,在学术癌症中心于2012年1月至2015年6月纳入临床局限于子宫的子宫内膜癌患者。
  • 共纳入200例,194例符合分析条件。
  • 按Mayo Clinic既定方案,依据细胞类型、肿瘤分级、肌层浸润和肿瘤大小术中分为低危和高危两组。
  • 低危者接受筋膜外子宫切除加双侧输卵管卵巢切除;高危者接受完整手术分期,包括双侧盆腔及腹主动脉旁淋巴结清扫。

主要发现

  • 算法识别132例(68%)高危和62例(32%)低危癌症。
  • 高危者中126例接受淋巴结清扫,14例(11%)淋巴结转移阳性。
  • 5例高危者出现疾病复发。
  • 62例低危癌症中2例出现疾病复发。
  • 10例低危癌症因病灶大小(6例)和分级(4例)在最终病理上升级为高危,这些患者均未出现疾病复发。

关键数值与推荐

  • 高危定义为按Mayo Clinic方案依据细胞类型、肿瘤分级、肌层浸润和肿瘤大小判定的淋巴结受累风险。
  • 算法敏感性90%(18/20)、特异性36%(62/174)。

临床怎么用

  • 作者认为术中评估早期子宫内膜癌可用于确定手术分期范围。
  • 作者认为所研究算法特异性低,需修改以更好匹配手术方式与转移癌风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Prospectively validate an intraoperative surgical staging algorithm to stratify patients with early endometrial cancer by risk of lymph node metastasis. METHODS: Subjects with endometrial cancer clinically confined to the uterus were prospectively enrolled at an academic cancer center between Jan 2012 and Jun 2015. Study participants were stratified intraoperatively into two groups based on risk of nodal involvement using cell type, tumor grade, myometrial invasion, and tumor size in accordance with an established protocol from the Mayo Clinic. Low risk (LR) subjects received extrafascial hysterectomy with bilateral salpingo-oophorectomy; high risk (HR) patients received complete surgical staging including bilateral pelvic and para-aortic lymphadenectomy. RESULTS: Of the 200 subjects enrolled, 194 were eligible for analysis. The algorithm identified 132 (68%) HR and 62 (32%) LR cancers. Of the HR subjects, 126 had lymphadenectomy performed with 14 (11%) positive for nodal metastases. Five HR subjects experienced disease recurrence. Of the 62 LR cancers, two patients developed disease recurrence. Ten LR cancers were upgraded to HR on final pathology due to lesion size (6) and grade (4). None of these patients experienced disease recurrence. The algorithm demonstrated 90% sensitivity (18/20) and 36% specificity (62/174) as determined by positive lymph nodes and/or disease recurrence. CONCLUSIONS: Intraoperative assessment of early endometrial cancer can be used to determine the extent of surgical staging. The studied algorithm has low specificity and modifications are necessary to better match the surgical procedure to the risk of metastatic cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lefringhouse JR, Elder JW, Baldwin LA, et al. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer. Gynecol Oncol. 2017. PMID: 28190648. doi:10.1016/j.ygyno.2017.01.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。